An example is the treatment of HER2+ (positive) breast cancer with the nano drug P(100 kDa)/mPEG(5%)/LOEt(40%)/AON/Herceptin/m-TfR, which resulted in the complete regression of the breast cancer [24] (Figure 10). Here, ERBB2 is linked to breast carcinoma.